Abstract
Prostate cancer has emerged as the common malignancy in men and is considered as a global issue. Among different strategies to combat prostate cancer, nanobiotechnology appears as a novel approach for prostate cancer theranostics. The current systematic review discussing the recent development in the prostate anticancer activity of biologically synthesized silver nanoparticles (AgNPs) and gold nanoparticles (AuNPs) through laboratory investigations. The databases including Cochrane, Web of Science, PubMed, Scopus, Science Direct, ProQuest, and Embase were used to identify the records. It was found that most of the studies used herbal extracts for preparation of AgNPs and/or AuNPs. Majority of biosynthesized nanoparticles (NPs) were formed with spherical morphology. Besides, all studies reported the size of NPs less than 100 nm. Moreover, PC-3 prostate cancer cell was the predominant cell line that was evaluated for prostate anticancer activity of NPs. In the present study, we provided valuable information suggesting the significant prostate anticancer potential of biogenic AgNPs and/or AuNPs. However, further, in vivo investigations are required to provide stronger evidence of the efficacy of bio-mediated synthesized AgNPs and/or AuNPs to combat prostate cancer.
Similar content being viewed by others
References
S. Zaidi, J. Gandhi, G. Joshi, N. L. Smith, and S. A. Khan (2019). Prostate Cancer Prostatic Dis.. https://doi.org/10.1038/s41391-018-0085-2.
O. Sartor and J. S. de Bono (2018). N. Engl. J. Med. 378, 645.
R. L. Siegel, K. D. Miller, and A. Jemal (2019). CA Cancer J. Clin. 69, 7.
American Cancer Society Cancer Facts & Figures 2019 (American Cancer Society, Atlanta, 2019).
J. Ferlay, M. Colombet, I. Soerjomataram, T. Dyba, G. Randi, M. Bettio, A. Gavin, O. Visser, and F. Bray (2018). Eur. J. Cancer 103, 356.
D. Cunningham and Z. You (2015). J. Biol. Methods 2, e17.
J. C. Henegan and G. Sonpavde (2018). Exp. Opin. Biol. Ther. 18, 109.
V. K. Lakshmanan (2016). Investig. Clin. Urol. 57, 21.
H. Barabadi, M. A. Mahjoub, B. Tajani, A. Ahmadi, Y. Junejo, and M. Saravanan (2019). J. Clust. Sci. 30, 259.
H. Barabadi (2017). Cell. Mol. Biol. 63, 3.
H. Barabadi, F. Kobarfard, and H. Vahidi (2018). Iran J. Pharm. Res. 17, 87.
H. Barabadi, A. Alizadeh, M. Ovais, A. Ahmadi, Z. K. Shinwari, and M. Saravanan (2018). IET Nanobiotechnol. 12, 377.
H. Barabadi, M. Ovais, Z. K. Shinwari, and M. Saravanan (2017). Green Chem. Lett. Rev. 10, 285.
H. Barabadi, S. Honary, P. Ebrahimi, M. A. Mohammadi, A. Alizadeh, and F. Naghibi (2014). Braz. J. Microbiol. 45, 1493.
H. Barabadi, Z. Alizadeh, M. T. Rahimi, A. Barac, A. E. Maraolo, L. J. Robertson, A. Masjedi, F. Shahrivar, and E. Ahmadpour (2019). Nanomedicine: NBM 18, 221.
N. Karimi, A. Chardoli, and A. Fattahi (2017). Iran. J. Pharm. Res. 16, 1167.
S. Salari, S. Esmaeilzadeh Bahabadi, A. Samzadeh-Kermani, and F. Yousefzaei (2019). Iran. J. Pharm. Res. 18, 430.
Z. Rezvani Amin, Z. Khashyarmanesh, B. S. Fazly Bazzaz, and Z. Sabeti Noghabi (2019). Iran. J. Pharm. Res. 18, 210.
T. Ramezani, M. Nabiuni, J. Baharara, K. Parivar, and F. Namvar (2019). Iran. J. Pharm. Res. 18, 222.
M. M. Or Rashid, M. S. Islam, M. A. Haque, M. A. Rahman, M. T. Hossain, and M. A. Hamid (2016). Iran. J. Pharm. Res. 15, 591.
R. Dobrucka (2017). Iran. J. Pharm. Res. 16, 753.
Q. Abbas, M. Saleem, A. R. Phull, M. Rafiq, M. Hassan, K.-H. Lee, and S.-Y. Seo (2017). Iran. J. Pharm. Res. 16, 760.
H. Barabadi, B. Tajani, M. Moradi, K. Damavandi Kamali, R. Meena, S. Honary, M. A. Mahjoub, and M. Saravanan (2019). J. Clust. Sci.. https://doi.org/10.1007/s10876-019-01554-3.
P. Boomi, G. P. Poorani, S. Palanisamy, S. Selvam, G. Ramanathan, S. Ravikumar, H. Barabadi, H. G. Prabu, J. Jeyakanthan, and M. Saravanan (2019). J. Clust. Sci. 30, 715.
K. Rasmussen, H. Rauscher, A. Mech, J. Riego Sintes, D. Gilliland, M. Gonzalez, P. Kearns, K. Moss, M. Visser, M. Groenewold, and E. A. J. Bleeker (2018). Regul. Toxicol. Pharmacol. 92, 8.
B. D. Chithrani, A. A. Ghazani, and W. C. Chan (2006). Nano Lett. 6, 662.
S. Hauert and S. N. Bhatia (2014). Trends Biotechnol. 32, 448.
M. S. Bethu, V. R. Netala, L. Domdi, V. Tartte, and V. R. Janapala (2018). Artif. Cells Nanomed. Biotechnol. 46, S104.
M. S. Bethu and J. Venkateswara Rao (2017). Asian J. Pharm. Clin. Res. 10, 65.
A. Parveen and S. Rao (2015). J. Clust. Sci. 26, 775.
E. B. El Domany, T. M. Essam, A. E. Ahmed, and A. A. Farghali (2018). J. Appl. Pharm. Sci. 8, 119.
K. Kalaiarasi, G. Prasannaraj, S. V. Sahi, and P. Venkatachalam (2015). Turk. J. Biol. 39, 223.
G. Prasannaraj, S. V. Sahi, S. Ravikumar, and P. Venkatachalam (2016). J. Nanosci. Nanotechnol. 16, 4948.
G. Prasannaraj and P. Venkatachalam (2017). Adv. Nat. Sci. Nanosci. 8, 025001.
K. Rajathi, N. Kannikaparameswari, and S. Suja (2017). Eur. J. Pharm. Sci. 4, 401.
H. Barabadi, S. Honary, M. Ali Mohammadi, E. Ahmadpour, M. T. Rahimi, A. Alizadeh, F. Naghibi, and M. Saravanan (2017). Environ. Sci. Pollut. Res. Int. 24, 5800.
M. J. Firdhouse and P. Lalitha (2013). Cancer Nanotechnol. 4, 137.
Y. He, Z. Du, S. Ma, S. Cheng, S. Jiang, Y. Liu, D. Li, H. Huang, K. Zhang, and X. Zheng (2016). Nanoscale Res. Lett. 11, 300.
Y. Q. He, X. Li, Y. Y. Zheng, Z. Y. Wang, Z. Y. Ma, Q. Yang, B. H. Yao, Y. J. Zhao, and H. Zhang (2018). New J. Chem. 42, 2882.
J. Raman, G. R. Reddy, H. Lakshmanan, V. Selvaraj, B. Gajendran, R. Nanjian, A. Chinnasamy, and V. Sabaratnam (2015). Process Biochem. 50, 140.
Y. Q. He, X. Li, J. Wang, Q. Yang, B. H. Yao, Y. J. Zhao, A. M. Zhao, W. X. Sun, and Q. Zhang (2017). Environ. Toxicol. Pharmacol. 56, 56.
R. E. Heravi, S. Zakeri, and P. Nazari (2018). Micro Nano Lett. 13, 1475.
K. Jadhav, S. Deore, D. Dhamecha, H. R. Rajeshwari, S. Jagwani, S. Jalalpure, and R. Bohara (2018). ACS Biomater. Sci. Eng. 4, 892.
D. G. Kumar, N. S. Raj, R. Kumar, and K. S. Nagendra (2017). Int. Res. J. Pharm. 8, 109.
R. I. Priyadharshini, G. Prasannaraj, N. Geetha, and P. Venkatachalam (2014). Appl. Biochem. Biotechnol. 174, 2777.
O. S. Adeyemi and F. A. Sulaiman (2015). J. Biomed. Res. 29, 145.
K. M. Ardhendu (2017). Glob. J. Nanomed. 3, 555607.
S. Khalid and R. Hanif (2017). IJASET 5, 59.
M. Naz, N. Nasiri, M. Ikram, M. Nafees, M. Z. Qureshi, S. Ali, and A. Tricoli (2017). Appl. Nanosci. 7, 793.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Barabadi, H., Damavandi Kamali, K., Jazayeri Shoushtari, F. et al. Emerging Theranostic Silver and Gold Nanomaterials to Combat Prostate Cancer: A Systematic Review. J Clust Sci 30, 1375–1382 (2019). https://doi.org/10.1007/s10876-019-01588-7
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10876-019-01588-7